Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT06790602 · RECRUITING

Trial details

NCT number: NCT06790602
Sponsor: University of California, San Diego
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (mPDAC)

Start date: 2026-05-06
Primary completion: 2028-07-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.